SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Arima Genomics to Showcase Aventa Tests at AMP 2026

The company says research on Aventa FusionPlus and Aventa Lymphoma spans salivary gland cancer, breast cancer and T-cell lymphoma.

Related stories